Nanochon develops 3D-printed, off-the-shelf implants designed to facilitate natural cartilage repair in orthopedic patients. Their Chondrograft™ implant uses a press-fit procedure to integrate with the damaged area, drawing in biological cells to support tissue regeneration. This technology offers orthopedic surgeons an accessible alternative to joint replacement for patients with focal cartilage defects.
Funding
Funding not disclosed
Founders
Product
Problem
Current treatments for joint injuries, such as cartilage loss and sports-related damage, often involve lengthy recovery periods and may not fully restore joint function, particularly for active individuals. Existing solutions may not adequately address the needs of younger patients seeking a return to full activity.
Solution
Nanochon is developing a minimally invasive, 3D-printed implant designed to facilitate faster recovery and improved outcomes for individuals with joint injuries. The implant utilizes biologically-inspired nanomaterials to replace damaged cartilage and encourage new tissue growth. This approach aims to enable immediate weight-bearing and motion, reducing the recovery time typically associated with traditional treatments. By combining 3D printing, advanced materials, and computer-aided design, Nanochon seeks to provide a cost-effective solution that restores joint function and allows patients to return to an active lifestyle.
Target Audience
The primary target audience includes patients aged 18 and over suffering from sports injuries, tears, and early-stage cartilage loss, particularly those seeking a faster return to an active lifestyle.
Features
- 3D-printed implant using biologically-inspired nanomaterials
- Minimally invasive surgical procedure
- Designed to enable immediate weight-bearing and motion
- Aims to replace lost and damaged cartilage
- Encourages new tissue growth within the joint
- Intended as an off-the-shelf device for cost-effectiveness